Announcements Trials
Browse Landscape

Status

Completed 24Recruiting 14Unknown 7Not yet recruiting 5Active not recruiting 4Terminated 3Withdrawn 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Breast 1

Conditions

Breast Neoplasms 16Neoplasms 11Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 5Prostatic Neoplasms 4Lung Neoplasms 4Polycystic Ovary Syndrome 3Ovarian Neoplasms 3Glioblastoma 3Diabetes Mellitus 3Crohn Disease 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Non-alcoholic Fatty Liver Disease 2Multiple Sclerosis 2Irritable Bowel Syndrome 2Glioma 2Endometrial Neoplasms 2Dyslipidemias 2Colonic Neoplasms 2Colitis, Ulcerative 2Celiac Disease 2Carcinoma, Renal Cell 2Arthritis, Rheumatoid 2Vulvar Diseases 1Vitamin D Deficiency 1

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Observational × Uterine Neoplasms × Clear all
NCT03987555 2026-03-18

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Wake Forest University Health Sciences

Suspended
22 enrolled
BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡